CURX vs SNOW · $8.9M cap vs rev $1.55B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy Ph.D..
CURX does not have a complete income-statement cache yet.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
CURX currently screens at market cap $8.9M. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the CURX and SNOW stock pages for the full models.
Not investment advice.